Sensitivity of intravenous and oral alfentanil and pupillary miosis as minimally invasive and noninvasive probes for hepatic and first-pass CYP3A activity.
about
Importance of multi-p450 inhibition in drug-drug interactions: evaluation of incidence, inhibition magnitude, and prediction from in vitro dataAssessment of algorithms for predicting drug-drug interactions via inhibition mechanisms: comparison of dynamic and static models.Effects of the moderate CYP3A4 inhibitor, fluconazole, on the pharmacokinetics of fesoterodine in healthy subjects.Sensitivity of intravenous and oral alfentanil and pupillary miosis as minimal and noninvasive probes for hepatic and first-pass CYP3A induction.Concurrent assessment of hepatic and intestinal cytochrome P450 3A activities using deuterated alfentanilRole of cytochrome P4502B6 in methadone metabolism and clearance.CYP3A activity: towards dose adaptation to the individual.
P2860
Q27009128-F9484211-2F98-4A88-98FB-ECBADF598872Q34476096-BF3637BB-2FFF-40AE-B6B5-89AF8B7ADC49Q35183627-A2E47F4C-DC04-40A9-9FCD-3A7B568A2951Q36578060-F122DD47-BD57-4B93-9B8F-D4E8D5252F4BQ36646017-4509AA70-4134-4ACD-A858-A03F3E844C9EQ37094439-D7372471-9982-4141-974B-DF7D9B440FF2Q38763583-790BAEC9-5744-4148-BCD4-107F85FC9DA8
P2860
Sensitivity of intravenous and oral alfentanil and pupillary miosis as minimally invasive and noninvasive probes for hepatic and first-pass CYP3A activity.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh-hant
name
Sensitivity of intravenous and ...... and first-pass CYP3A activity.
@en
Sensitivity of intravenous and ...... and first-pass CYP3A activity.
@nl
type
label
Sensitivity of intravenous and ...... and first-pass CYP3A activity.
@en
Sensitivity of intravenous and ...... and first-pass CYP3A activity.
@nl
prefLabel
Sensitivity of intravenous and ...... and first-pass CYP3A activity.
@en
Sensitivity of intravenous and ...... and first-pass CYP3A activity.
@nl
P2093
P2860
P356
P1476
Sensitivity of intravenous and ...... and first-pass CYP3A activity.
@en
P2093
Alysa Walker
Christine Hoffer
Evan D Kharasch
Pamela Sheffels
P2860
P304
P356
10.1177/0091270005280077
P577
2005-10-01T00:00:00Z